Key facts
- NUA Surgical’s last known valuation is $5.2M (Jun 2024).
- It has raised $8.5M; the latest was Later Stage VC ($6.9M) in Dec 2024.
- Notable investors include Techstars, Enterprise Ireland, Impact Assets, Texas Medical Center, Matter (Consulting Services (B2B)) — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for NUA Surgical
- ·The full record, as it builds
Funding rounds
No funding rounds for NUA Surgical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About NUA Surgical
Manufacturer of surgical instruments intended to enhance safety and efficiency in obstetrics and gynaecology. The company's device features a patented disposable C-Section retractor designed to improve surgical ergonomics and minimize complications during caesarean deliveries, enabling healthcare providers to deliver safer care for mothers and infants while addressing critical clinical needs in women's health.
- Sector
- Healthcare
- HQ
- Galway, Ireland
- Founded
- 2018
- Employees
- 10
- Website
- nuasurgical.com/
- Ownership
- Privately Held (backing)
NUA Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NUA Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NUA Surgical in its N-PORT filings yet. We sweep new filings monthly.